CSBR

CHAMPIONS ONCOLOGY, INC.

CSBR · CIK 771856 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$57M
20182025
Net Income$5M
20182025
Operating CF$7M
20182025
Free Cash Flow$7M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B—
Cost of Revenue$0.0B$0.0B$0.0B$0.0B$0.0B———
Gross Profit————————
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense————————
Operating Income$0.0B$-0.0B$-0.0B$0.0B$0.0B$-0.0B$0.0B$-0.0B
Net Income$0.0B$-0.0B$-0.0B$0.0B$0.0B$-0.0B$0.0B$-0.0B
EPS (Basic)$0.34$-0.54$-0.39$0.04$0.03$-0.17$0.01—
EPS (Diluted)$0.33$-0.54$-0.39$0.04$0.02$-0.17$0.01—

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$-0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.0B$-0.0B$0.0B$0.0B$-0.0B$0.0B$0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$-0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
← Companies